1-2 of 2
Monette Aujay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors

Open Access
Wolf R. Wiedemeyer, Julia Gavrilyuk, Alexander Schammel, Xi Zhao, Hetal Sarvaiya, Marybeth Pysz, Christine Gu, Monica You, Kumiko Isse, Theodore Sullivan, Dorothy French, Christina Lee, Angeline T. Dang, Zhaomei Zhang, Monette Aujay, Alexander J. Bankovich, Philip Vitorino
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (6): 986–998.
https://doi.org/10.1158/1535-7163.MCT-21-0851
Published: 01 June 2022
View articletitled, ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors
Open the PDF for ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors in another window
Includes: Supplementary data
Journal Articles

Pharmacodynamic, pharmacokinetic and anti-tumor properties of orally bioavailable inhibitors of the 20S proteasome

Free
Jing Jiang, Monette Aujay, Mark Bennett, Maya Dajee, Ying Fang, Mark Ho, Christopher Kirk, Evan Lewis, Yan Lu, Guy Laidig, Tony Muchamuel, Kevin Shenk, Congcong Sun, Catherine Sylvain, Tina Woo, Jinfu Yang, Han-Jie Zhou
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C227.
Published: 01 November 2007
View articletitled, Pharmacodynamic, pharmacokinetic and anti-tumor properties of orally bioavailable inhibitors of the 20S proteasome